Newly Published Visiongain Report: Global Opioids Market Report 2019-2029
Market Overview and Trends
-The rising frequency of disease conditions with severe pain, such as lower back pain, cancer, fibromyalgia and arthritis are driving the opioids market.
-The market is projected to be driven by the growing geriatric population, along with increasing focus on palliative care.
-Due to the considerable number of drug-abuse deaths registered in the country the market is being strictly regulated by the U.S. FDA. The FDA has discovered certain guidelines to manufacture, store, market and sell opioid products.
-The U.S. FDA discontinued the most widely prescribed opioids, Vicodin (Hydrocodone)
Purchase full report or download free sample pages: https://www.visiongain.com/
Market Segmentation 2019-2029:
The Global Opioids Market is segmented on the Product, Application and Region.
1. Global Opioids Market, by Product
2. Global Opioids market, by Application
a) Pain Management
– Neuropathic Pain
– Back Pain
– Osteoarthritis Pain
– Cancer Pain
b) Cold and Cough
d) Other Applications
3. Global Opioids market, by Region
a) North America
– Rest of Europe
c) Asia Pacific
– Rest of Asia Pacific
d) Rest of the World (RoW)
-Research and development is the primary strategy adopted by the key players in the Global Biodefense market.
-These companies have developed various strategies and developments such as product launch, partnerships, mergers & acquisitions, joint venture, and collaborations.
Major Market Players:
Pfizer Inc., Purdue Pharma, Boehringer Ingelheim, Janssen Pharmaceuticals, Inc., Actavis Plc., Sanofi, Sun Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Endo Pharmaceuticals Inc. and Egalet.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
020 7549 9987